<!DOCTYPE html>
<html>
    <head>
        <title>Ulta Beauty, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
        <link href="https://ir.stockpr.com/ulta/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
        <script type="text/javascript" src="https://ir.stockpr.com/javascripts/ir.js"></script>
        <link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
        <script type="text/javascript" src="https://d1io3yog0oux5.cloudfront.net/_d3f702ef508aa7a9103e5dd0b5b371e3/ulta/files/theme/js/aside/ir/_js/all.js"></script>
    </head>
    <body>
        <div class="xbrl-content">
            <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
            <div id="xbrl-menu-top">
                <div class="navigation">
                    <ul class="xbrl-sf-menu">
                        
                            <li>
                                <a class="menu-item " href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/828">Cover</a>
                                <ul class="submenu">
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/828">Document and Entity Information</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/829">Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/829">Consolidated Balance Sheets</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/830">Consolidated Balance Sheets (Parenthetical)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/831">Consolidated Statements of Operations</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/832">Consolidated Statements of Comprehensive Income</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/833">Consolidated Statements of Cash Flows</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/834">Consolidated Statements of Stockholders&#039; Equity</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/835">Notes to Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/835">Business and basis of presentation</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/836">Summary of significant accounting policies</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/837">Impact of the COVID-19 pandemic</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/838">Revenue</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/839">Impairment, restructuring and other costs</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/840">Goodwill and Other Intangible Assets</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/841">Leases</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/842">Commitments and contingencies</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/843">Debt</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/844">Fair value measurements</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/845">Investments</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/846">Stock-based compensation</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/847">Income Taxes</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/848">Net income per common share</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/849">Share repurchase program</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/850">Accounting Policies</a>
                                <ul class="submenu">
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/850">Summary of significant accounting policies (Policies)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/851">Notes Tables</a>
                                <ul class="submenu">
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/851">Business and basis of presentation (Tables)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/852">Revenue (Tables)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/853">Impairment, restructuring and other costs (Tables)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/854">Leases (Tables)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/855">Stock-based compensation (Tables)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/856">Net income per common share (Tables)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/857">Share repurchase program (Tables)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item current" href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/858">Notes Details</a>
                                <ul class="submenu">
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/858">Business and basis of presentation (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/859">Summary of significant accounting policies (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/860">Impact of the COVID-19 pandemic (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/861">Revenue - Disaggregated revenue (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/862">Revenue - Deferred revenue (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/863">Impairment, restructuring and other costs - Impairment of long-lived tangible assets (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/864">Impairment, restructuring and other costs - Restructuring and other costs - Tabular disclosure (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/865">Impairment, restructuring and other costs - Restructuring and other costs - Restructuring accrual (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/866">Impairment, restructuring and other costs - Restructuring and other costs - Additional information (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/867">Goodwill and Other Intangible Assets (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/868">Leases - Lease costs (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/869">Leases - Cash flow information and non-cash activity (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/870">Debt (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/871">Fair value measurements (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/872">Investments (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/873">Stock-based compensation (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/874">Income Taxes (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/875">Net income per common share - Reconciliation (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/876">Net income per common share - Anti-dilutive Shares (Details)</a></li>
                                                                            <li><a href="/investor/sec-filings/quarterly-reports/xbrl_doc_only/877">Share repurchase program (Details)</a></li>
                                                                    </ul>
                            </li>
                                            </ul>
                </div>
            </div>
            <div class="spr-xbrl-document">
                <h4>Impact of the COVID-19 pandemic (Details)</h4>
                                <div style="clear:both;"></div>
            </div>
        </div>
    </body>
</html>